Promising new therapeutic approach for debilitating bone disease
(Garvan Institute of Medical Research) Australian researchers have demonstrated that a new type of therapeutic could greatly reduce bone disease in patients with the bone cancer, multiple myeloma. Multiple myeloma is a cancer that develops in bone, causing progressive bone destruction, bone fractures, and often devastating pain. Unlike existing treatments, this new approach rebuilds bone tissue, making it more resistant to fractures.This treatment could greatly reduce the debilitating pain of bone damage, transforming the prognosis for myeloma patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2017 Category: International Medicine & Public Health Source Type: news
The Brisbane boy with an upside down foot
Jonty Oddy, from Brisbane, Australia, was an active four-year-old, when he suddenly started limping as he walked. Doctors discovered his pained stemmed from an osteosarcoma. (Source: the Mail online | Health)
Source: the Mail online | Health - June 27, 2017 Category: Consumer Health News Source Type: news
What is bone cancer? Symptoms could be mistaken for THIS common condition
BONE cancer is a rare type of cancer - it affects just over 500 people every year. (Source: Daily Express - Health)
Source: Daily Express - Health - June 23, 2017 Category: Consumer Health News Source Type: news
Existing drugs could benefit patients with bone cancer, genetic study suggests
(Wellcome Trust Sanger Institute) A subgroup of patients with osteosarcoma -- a form of bone cancer -- could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators. In the largest genetic sequencing study of osteosarcoma to date, scientists discovered that 10 percent of patients with a genetic mutation in particular growth factor signalling genes may benefit from existing drugs, known as IGF1R inhibitors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 23, 2017 Category: Cancer & Oncology Source Type: news
Why Was a Teenager with Bone Cancer Buried on Witch Hill in 1300 AD
Report identifies bone tumor in upper right arm of adolescent buried around 1300 AD at a site in western Panama called Cerro Brujo or Witch Hill (Source: Disabled World)
Source: Disabled World - June 2, 2017 Category: Disability Tags: Anthropology Source Type: news
Why was a teenager with bone cancer buried on Witch Hill in Panama?
(Smithsonian Tropical Research Institute) Likely the first bone tumor from an ancient skeleton in Central America is reported by Smithsonian archaeologists and colleagues. The starburst-shaped tumor is in the upper right arm of the skeleton of an adolescent buried in about 1300 AD in a trash heap at a site in western Panama called Cerro Brujo or Witch Hill. The reason for what appears to be a ritual burial in this abandoned pre-Colombian settlement is unknown. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2017 Category: Cancer & Oncology Source Type: news
CPRIT grant brings personalized-modeling expert to Rice
(Rice University) Thanks to a new $5 million recruitment grant from the Cancer Prevention and Research Institute of Texas, bone cancer patients facing difficult pelvic surgeries in the Texas Medical Center could soon benefit from Rice University research that will use personalized computer models to predict surgical outcomes for patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2017 Category: International Medicine & Public Health Source Type: news
On Biotech: Aratana primes puppy pharma pipeline
Even as Aratana Therapeutics ramps up marketing for its current portfolio, the Leawood company continues to move new treatments for Fido through its development pipeline.
The star of the company’s May 9 investor call was Galliprant, a canine osteoarthritis treatment on its way to becoming a blockbuster. But Aratana’s plans include another treatment for more severe osteoarthritis cases, in addition to an immunotherapy treatment for bone cancer.
“Lately, a lot of the focus at Aratana has been… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 11, 2017 Category: Biotechnology Authors: Elise Reuter Source Type: news
On Biotech: Aratana primes puppy pharma pipeline
Even as Aratana Therapeutics ramps up marketing for its current portfolio, the Leawood company continues to move new treatments for Fido through its development pipeline.
The star of the company’s May 9 investor call was Galliprant, a canine osteoarthritis treatment on its way to becoming a blockbuster. But Aratana’s plans include another treatment for more severe osteoarthritis cases, in addition to an immunotherapy treatment for bone cancer.
“Lately, a lot of the focus at Aratana has been… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 11, 2017 Category: Health Management Authors: Elise Reuter Source Type: news
A protein, a 'molecular staple' and CRISPR to develop an Ewing sarcoma model
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma. The technique, based on CRISPR and described in the pages of Stem Cell Reports, makes it possible to generate cellular models to analyze the mechanisms underlying the origin and progression of this and other diseases, as well as the search for new treatments. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2017 Category: International Medicine & Public Health Source Type: news
Tumor Lysis Syndrome in an Extraskeletal Osteosarcoma Tumor Lysis Syndrome in an Extraskeletal Osteosarcoma
Tumor lysis syndrome is a major oncological emergency, usually associated with treatment of hematological tumors. What precipitated it in this patient, and how was it treated?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 5, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
What Charlotte Rae's Cancer Plan Reveals About Medical Decisions Late In Life
Actress Charlotte Rae, 91, has revealed that she was just diagnosed with bone cancer. And like many who get a diagnosis of a serious illness at an advanced age, her first decision wasn’t what the best treatment plan might be but rather whether she should seek treatment at all.
“At the age of 91, I have to make up my mind,” she told People magazine. “I’m not in any pain right now. I’m feeling so terrific and so glad to be above ground.”
Rae, who was treated for pancreatic cancer several years ago, added, “Now I have to figure out whether I want to go have treatment again ...
Source: Healthy Living - The Huffington Post - April 28, 2017 Category: Consumer Health News Source Type: news
FDA approves Radius Health osteoporosis drug, but adds cancer warning
The FDA on Friday approved an osteoporosis drug made by Waltham-based Radius Health, but added a so-called "black box" warning that the treatment had increased the risk of bone cancer in rats.
Radius (Nasdaq: RDUS) is hoping that abaloparatide, which will be sold under the brand name Tymlos, will eventually take on Forteo, an osteoporosis treatment sold by Eli Lilly (NYSE: LLY) that generated $1.5 billion in sales last year. Forteo has the same warning, which states that the drug increa sed the risk… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 28, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news
FDA approves Radius Health osteoporosis drug, but adds cancer warning
The FDA on Friday approved an osteoporosis drug made by Waltham-based Radius Health, but added a so-called "black box" warning that the treatment had increased the risk of bone cancer in rats.
Radius (Nasdaq: RDUS) is hoping that abaloparatide, which will be sold under the brand name Tymlos, will eventually take on Forteo, an osteoporosis treatment sold by Eli Lilly (NYSE: LLY) that generated $1.5 billion in sales last year. Forteo has the same warning, which states that the drug increa sed the risk… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 28, 2017 Category: American Health Authors: Max Stendahl Source Type: news
Girl With Cancer Receives American Girl Doll With Prosthetic Leg Like Hers
After losing her leg to cancer, a 10-year-old girl found companionship in a special doll with the same condition.
In November 2016, Dylan Probe was diagnosed with a type of bone cancer called Ewing’s sarcoma. The fourth-grader had to undergo chemotherapy and on March 17, had her right leg amputated below the knee.
Throughout Dylan’s battle with cancer, photographer Sherina Welch has documented her journey in the hospital. Following the surgery, Welch decided to surprise the brave little girl with an American Girl doll that has a prosthetic leg just like hers.
Welch ordered the doll from a company c...
Source: Healthy Living - The Huffington Post - April 14, 2017 Category: Consumer Health News Source Type: news
